← Eichor
Study identifier: NCT04055571 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Evaluation of Outcomes From Treatment of Benign or Malignant Pancreatic Diseases

Condition: Benign or Malignant Pancreatic Diseases  ·  Sponsor: Methodist Health System

PhaseN/A
Planned participants500
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study will be a retrospective chart review of patients who have been diagnosed with the benign or malignant pancreatic disease under the practice of Dr. Rohan Jeyarajah, M.D., Dr. Houssam Osman M.D., and Dr. Edward Cho M.D., Sc.M. at Methodist Health System Hospital in Richardson, Texas(TX). The investigators plan to conduct an analysis of patients meeting the inclusion criteria from 2005 to present. Study will also be conducted by the PI, Sub-Is, surgery fellows, office staff and clinical research coordinator who are delegated to do by the PI. Data will be obtained by looking through either investigator's patients or through a national database. Data will be analyzed primarily by the study conductors.

This description comes directly from the study's public registry record.

Talk to the study team

Crystee Cooper, DHEd  ·  214-947-1280  ·  CrysteeCooper@mhd.com

Nitasha Phatak, Ph.D.  ·  214-947-4459  ·  NitashaPhatak@mhd.com

Always discuss trial participation with your own doctor first.

Locations (1)

Trinity Surgical Consultants, Methodist Richardson Medical CenterRichardson, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04055571